Skip to main content

FDA Approvals

In-Depth Treatment Profile, FDA Approvals, Bispecific Antibodies

Epkinly Receives Accelerated Approval for Treatment of Follicular Lymphoma After ≥2 Lines of Systemic Therapy

Rohan Vashi, PharmD, MSc

Rohan Vashi, PharmD, MSc

In-Depth Treatment Profile, A Payer Perspective, FDA Approvals, Bispecific Antibodies

Bispecific Antibody Columvi Offering Option in Diffuse Large B-cell Lymphoma Treatment

Rohan Vashi, PharmD, MSc

Rohan Vashi, PharmD, MSc

Directory of Novel FDA Approvals, 2024

FDA OKs Revumenib for Relapsed, Refractory Acute Leukemia With KMT2A Translocation

FDA OKs At-Home Influenza Vaccine

FDA OKs Lazertinib With Amivantamab-vmiw for NSCLC

Directory of FDA Approvals, August Through December 2023

Iwilfin FDA Approved for Adults and Pediatric Patients with High-Risk Neuroblastoma

Welireg Now FDA Approved for Patients with Advanced Renal Cell Carcinoma

Ogsiveo First Treatment FDA Approved for Desmoid Tumors

Page 2 of 53
Results 11 - 20 of 527